Silexion Therapeutics (SLXN) Current Assets (2023 - 2026)
Silexion Therapeutics (SLXN) posted quarterly Current Assets of $4.1 million for Q1 2026, down 47.36% year-over-year from $7.7 million in Q1 2025, and down 38.75% quarter-over-quarter from $6.6 million in Q4 2025.
Silexion Therapeutics (SLXN) Current Assets (2023 - 2026) Analysis & Trends
Silexion Therapeutics' Current Assets history runs 4 years deep, the most recent figure standing at $4.1 million for Q1 2026.
- In Q1 2026, Current Assets fell 47.36% year-over-year to $4.1 million; the TTM figure through Mar 2026 stood at $4.1 million (down 47.36% YoY), while the FY2025 annual figure was $6.6 million, up 194.98% from the prior year.
- Current Assets for Q1 2026 stood at $4.1 million, down from $6.6 million in the prior quarter.
- The five-year high for Current Assets was $11.1 million in Q3 2025, with the low at $2.2 million in Q4 2024.
- The 4-year median for Current Assets is $5.0 million (2023), against an average of $5.3 million.
- The sharpest annual moves came in 2024 and 2025: Current Assets tumbled 54.81% in 2024, then surged 262.82% in 2025.
- Silexion Therapeutics' Current Assets stood at $5.0 million in 2023, then sank by 54.81% to $2.2 million in 2024, then jumped by 194.98% to $6.6 million in 2025, then slumped by 38.75% to $4.1 million in 2026.
- Business Quant data shows SLXN's Current Assets at $4.1 million in Q1 2026, $6.6 million in Q4 2025, and $11.1 million in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Current Assets (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 139.13 Bn | 131.28 Bn | 2.84 Bn | 12.54 Bn |
| 2 | Regeneron Pharmaceuticals | 85.77 Bn | 77.77 Bn | 3.93 Bn | 18.45 Bn |
| 3 | Argenx Se | 64.64 Bn | 59.46 Bn | 1.37 Bn | 8.07 Bn |
| 4 | Moderna | 58.29 Bn | 53.16 Bn | 52.00 Mn | 5.82 Bn |
| 5 | BeOne Medicines | 41.92 Bn | 36.82 Bn | 1.53 Bn | 7.22 Bn |
| 6 | Alnylam Pharmaceuticals | 31.58 Bn | 28.28 Bn | 992.69 Mn | 4.62 Bn |
| 7 | BioNTech SE | 28.12 Bn | 9.73 Bn | 668.28 Mn | 18.80 Bn |
| 8 | Insmed | 27.39 Bn | 26.22 Bn | 358.27 Mn | 1.63 Bn |
| 9 | Royalty Pharma | 27.27 Bn | 26.43 Bn | - | 1.76 Bn |
| 10 | Silexion Therapeutics | 266,692.97 | -1.96 Mn | - | 3.74 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 3.74 Mn |
| Mar 31, 2026 | 4.07 Mn |
| Dec 31, 2025 | 6.64 Mn |
| Sep 30, 2025 | 11.06 Mn |
| Jun 30, 2025 | 5.24 Mn |
| Mar 31, 2025 | 7.72 Mn |
| Dec 31, 2024 | 2.25 Mn |
| Sep 30, 2024 | 3.05 Mn |
| Jun 30, 2024 | 2.32 Mn |
| Dec 31, 2023 | 4.98 Mn |